Valeo Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of VP2?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,694,1451.72%
Individual Insiders23,609,19323.9%
Public Companies25,372,98725.7%
General Public47,999,10248.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 11 shareholders own 51.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25.7%
Manitex Capital Inc.
25,372,987€126.9k0%no data
16.4%
Richard MacKay
16,222,751€81.1k0%no data
3.08%
Luc Mainville
3,041,055€15.2k0%no data
2.36%
Marc Leger
2,331,414€11.7k0%no data
1.72%
Simcor Canada Holdings, Inc.
1,694,145€8.5k0%no data
1.38%
Nathalie Therrien
1,358,369€6.8k0%no data
0.26%
Frédéric Dumais
258,500€1.3k0%no data
0.18%
Steven Saviuk
180,745€903.70%no data
0.18%
Robert Raich
175,000€875.00%no data
0.022%
Nelly Komari
21,965€109.80%no data
0.02%
Kyle Steiger
19,394€96.90%no data